Biolase (BIOL) Reports In-Line Q2 EPS, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
BIOLASE Reports 2018 Second Quarter Results
August 8, 2018 8:30 AM EDTIRVINE, Calif., Aug. 8, 2018 /PRNewswire/ --Â BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today reported its financial results for its second quarter and six months ended June 30, 2018.
Worldwide net revenue for the 2018 second quarter was $12.2 million compared to $12.6 million for the year-ago period, which included revenue from a large one-time purchase of non-core imaging... More



